PSEN1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.11022302462516E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.71680036642874E-10 |
Normal-vs-Stage2 |
5.68019964397593E-10 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
7.66750000000815E-05 |
Stage1-vs-Stage2 |
3.205900E-02 |
Stage1-vs-Stage3 |
1.26379999798587E-08 |
Stage1-vs-Stage4 |
1.488600E-01 |
Stage2-vs-Stage3 |
1.393000E-01 |
Stage2-vs-Stage4 |
8.839400E-01 |
Stage3-vs-Stage4 |
4.915800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.44089209850063E-16 |
Normal-vs-AfricanAmerican |
2.843300E-04 |
Normal-vs-Asian |
1.597630E-01 |
Caucasian-vs-AfricanAmerican |
4.357800E-01 |
Caucasian-vs-Asian |
2.231800E-01 |
AfricanAmerican-vs-Asian |
4.440200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.7715611723761E-16 |
Normal-vs-Female |
6.98600066684207E-11 |
Male-vs-Female |
9.326500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.50759999986805E-07 |
Normal-vs-Age(41-60Yrs) |
3.58539999911756E-08 |
Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(81-100Yrs) |
1.47369999536906E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.176600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.245800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.164400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.292430E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.286300E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.490800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.083600E-01 |
Normal-vs-Grade 2 |
4.11359835084113E-11 |
Normal-vs-Grade 3 |
<1E-12 |
Normal-vs-Grade 4 |
2.47700000000073E-05 |
Grade 1-vs-Grade 2 |
8.112200E-02 |
Grade 1-vs-Grade 3 |
3.010300E-02 |
Grade 1-vs-Grade 4 |
2.353600E-02 |
Grade 2-vs-Grade 3 |
5.005800E-04 |
Grade 2-vs-Grade 4 |
1.045990E-01 |
Grade 3-vs-Grade 4 |
6.344200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.98450170027809E-11 |
Normal-vs-ccB subtype |
3.33066907387547E-16 |
ccA subtype-vs-ccB subtype |
6.082300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.06410016751124E-10 |
Normal-vs-N1 |
1.06859998627584E-09 |
N0-vs-N1 |
2.719900E-02 |
|
|